Diabetes Care Devices - Sri Lanka

  • Sri Lanka
  • Revenue in the Diabetes Care Devices market market in Sri Lanka is anticipated to attain US$15.94m in 2024.
  • This revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 7.03%, leading to a market volume of US$22.39m by 2029.
  • In a global context, the largest revenue is expected to be generated the United States, with a figure of US$11,710.00m in 2024.
  • In Sri Lanka, the growing prevalence of diabetes is driving a significant demand for innovative diabetes care devices, enhancing patient management and treatment outcomes.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Sri Lanka is witnessing moderate growth, influenced by factors such as increasing prevalence of diabetes, rising health awareness, and the gradual adoption of advanced monitoring technologies among patients and healthcare providers.

Customer preferences:
Consumers in Sri Lanka are increasingly favoring user-friendly diabetes care devices that integrate technology to simplify management of their condition. There is a growing preference for smart glucose monitoring systems that provide real-time data and insights, reflecting a shift towards proactive health management. Additionally, younger demographics are embracing mobile health applications that facilitate better tracking and communication with healthcare providers. This trend is further supported by rising health consciousness and a cultural emphasis on preventive care, driving innovation in diabetes management solutions.

Trends in the market:
In Sri Lanka, the Diabetes Care Devices Market is experiencing a surge in demand for advanced glucose monitoring systems that harness digital technology for enhanced user experience. There is a notable shift towards devices that offer real-time data analytics, empowering patients to take charge of their health. Furthermore, mobile health applications are gaining traction among younger consumers, promoting better adherence to treatment and seamless communication with healthcare providers. This trend underscores a growing emphasis on preventive care and health awareness, presenting significant opportunities for industry stakeholders to innovate and expand their product offerings in the diabetes management sector.

Local special circumstances:
In Sri Lanka, the Diabetes Care Devices Market is influenced by unique geographical and cultural factors, including a diverse population with varying dietary habits and lifestyle choices. The prevalence of traditional medicine alongside modern healthcare creates a dual approach to diabetes management, where patients often seek holistic solutions. Additionally, the regulatory landscape encourages local manufacturers to innovate and adapt devices to meet specific regional needs, such as affordability and accessibility, ensuring that advanced glucose monitoring systems align with the country's healthcare goals.

Underlying macroeconomic factors:
The Diabetes Care Devices Market in Sri Lanka is significantly influenced by macroeconomic factors, including the overall economic stability of the country, foreign direct investment, and healthcare spending. Rising disposable incomes and urbanization are driving demand for advanced diabetes management solutions, while government initiatives aimed at improving healthcare accessibility further stimulate market growth. Additionally, global trends such as increasing diabetes prevalence and advancements in medical technology encourage local manufacturers to innovate. However, fluctuating currency rates and import tariffs can impact the affordability of imported devices, challenging market performance.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)